Samantha McLemore - Patient Capital Management,
Holding/activity history for Biogen Inc. (BIIB)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 379,741 | 2.60 | Reduce 34.11% | 1.34 | $183.33 | $69,618,001 | SEC |
| 2025 Q4 | 576,352 | 3.92 | Add 45.31% | 1.22 | $175.99 | $101,432,302 | SEC |
| 2025 Q3 | 396,649 | 2.22 | Add 23.77% | 0.43 | $140.08 | $55,562,531 | SEC |
| 2025 Q2 | 320,466 | 1.82 | Reduce 29.66% | 0.95 | $125.59 | $40,247,340 | SEC |
| 2025 Q1 | 455,605 | 3.21 | Add 10.06% | 0.29 | $136.84 | $62,345,003 | SEC |
| 2024 Q4 | 413,960 | 2.92 | Add 61.74% | 1.11 | $152.92 | $63,302,707 | SEC |
| 2024 Q3 | 255,942 | 2.44 | Reduce 0.52% | 0.02 | $193.84 | $49,611,832 | SEC |
| 2024 Q2 | 257,269 | 3.17 | Add 18.07% | 0.49 | $231.82 | $59,640,080 | SEC |
| 2024 Q1 | 217,887 | 2.29 | Buy | 2.29 | $215.63 | $46,983,015 | SEC |